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Difference in expression between AQP1
and AQP5 in porcine endometrium and
myometrium in response to steroid
hormones, oxytocin, arachidonic acid,
forskolin and cAMP during the mid-luteal
phase of the estrous cycle and luteolysis
Agnieszka Skowronska1*, Patrycja Mlotkowska2, Soren Nielsen3 and Mariusz T. Skowronski2
Abstract
Background: Recently, we demonstrated in vitro that AQP1 and AQP5 in the porcine uterus are regulated by steroid
hormones (P4, E2), arachidonic acid (AA), forskolin (FSK) and cAMP during the estrous cycle. However, the potential of the
porcine separated uterine tissues, the endometrium and myometrium, to express these AQPs remains unknown. Thus, in
this study, the responses of AQP1 and AQP5 to P4, E2 oxytocin (OT), AA, FSK and cAMP in the porcine endometrium and
myometrium were examined during the mid-luteal phase of the estrous cycle and luteolysis.
Methods: Real-time PCR and western blot analysis.
Results: Progesterone up-regulated the expression of AQP1/AQP5 mRNAs and proteins in the endometrium and
myometrium, especially during luteolysis. Similarly, E2 also stimulated the expression of both AQPs, but only in the
endometrium. AA led to the upregulation of AQP1/AQP5 in the endometrium during luteolysis. In turn, OT increased the
expression of AQP1/AQP5 mRNAs and proteins in the myometrium during mid-luteal phase. Moreover, a stimulatory
effect of forskolin and cAMP on the expression of AQP1/AQP5 mRNAs and proteins in the endometrium and
myometrium dominated during luteolysis, but during the mid-luteal phase their influence on the expression of these
AQPs was differentiated depending on the type of tissue and the incubation duration.
Conclusions: These results seem to indicate that uterine tissues; endometrium and myometrium, exhibit their own AQP
expression profiles in response to examined factors. Moreover, the responses of AQP1/AQP5 at mRNA and protein levels
to the studied factors in the endometrium and myometrium are more pronounced during luteolysis. This suggests that
the above effects of the studied factors are connected with morphological and physiological changes taking place in the
pig uterus during the estrous cycle.
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Background
The uterine wall is composed of two functional compart-
ments, the endometrium and myometrium, surrounded
by the perimetrium [1]. The porcine endometrium com-
prises the luminal epithelial, glandular epithelial and stro-
mal cells [2]. In turn, the porcine myometrium consists of
outer and inner layers of smooth muscles; longitudinally-
and circularly-oriented to the uterine lumen, respectively
[3]. On the basis of in vitro studies, Franczak and Kotwica
[4], and Wojciechowicz et al. [5] reported that both por-
cine endometrium and myometrium are steroidogenic tis-
sues producing progesterone, estrogens and androgens.
Other reports indicate that porcine endometrium [6–8] as
well as myometrium [9, 10] also produce PGE2 and
PGF2alpha. As a result of ovarian steroid action, the uter-
ine glands expand and the secretory activity increases,
becoming the highest at the end of the secretory phase,
while during luteolysis, under the influence of oxytocin
(OT), uterine fluids and unnecessary cell debris are ex-
creted [11, 12].
Aquaporins (AQPs) are ubiquitous membrane proteins
which provide a molecular basis for transmembrane
water transport [13]. AQPs are constitutively expressed
in the cell membranes, to where they may be trafficked
from intracellular vesicles upon appropriate stimulation
[14]. So far, at least nine AQP isoforms (including AQP1
and AQP5) have been confirmed in the female repro-
ductive system of humans, rats, mice and pigs [15].
AQP1 is found in many secretory and osmotically-active
tissues [16], and is expressed in vascular endothelial cells
throughout the body [17, 18]. AQP5 is mainly located in
the apical plasma membranes of various secretory glands
[19]. Studies with animal models and humans have
shown that sufficient expression and proper subcellular
targeting of AQP5 channels are necessary to support
physiological functions [20–22]. The transport and
homeostasis of water in the endometrium is crucial for
maintaining proper reproductive processes. Previous
reports have demonstrated that the vasculature and epi-
thelium of the uterus have high expression of AQPs
[23–25] and that uterine fluid homeostasis is effectively
regulated by steroid hormones [26].
Our previous research indicated that AQP1, 5 and 9
are expressed in the porcine uterus, [27, 28], oviduct
[29], ovary [30] and peri-ovarian vascular complex [31].
We also observed that these AQPs are differently local-
ized and expressed in these structures during the estrous
cycle and early pregnancy. Very recently, we described
the response of AQPs (AQP1 and AQP5) to treatments
with steroids, OT, arachidonic acid (AA), forskolin (FSK)
and cAMP in the uterine explants from cyclic gilts dur-
ing the mid-luteal phase (Days 10–12) and luteolysis
(Days 14–16) [32]. However, to date, the potential of the
porcine uterine tissues, endometrium and myometrium
to express AQPs has not been studied separately. There-
fore, the objectives of the study were: 1/ to describe
endometrial and myometrial basal expression of AQP1/
AQP5 mRNAs and proteins during Days 10–12 (the
mid-luteal phase) and Days 14–16 (luteolysis) of the es-
trous cycle; 2/ to evaluate whether the steroid hormones
(P4 and E2), OT, AA (substrate for prostaglandin syn-
thesis), FSK (adenylate cyclase activator) and cAMP
(cyclic adenosine monophosphate; second messenger)
may regulate the endometrial and myometrial AQP1
and AQP5 expression at the mRNA and protein levels
during these periods. It is assumed that the obtained re-
sults will provide useful information on the regulatory
mechanism concerning the examined aquaporins in the
porcine endometrium and myometrium.
Methods
Animals and sample collection
All experiments were performed in accordance with the
Animal Ethics Committee, University of Warmia and
Mazury in Olsztyn, Poland (AEC approval No. 66/2010/
DTN). Tissue samples were recovered from mature
cross-bred gilts (Large White × Polish Landrace) on Days
10–12 (n = 5) and Days 14–16 (n = 5) of the estrous
cycle (the stage of luteolysis). Gilts were observed daily
for estrous behavior and they were used in the study
during their third consecutive normal estrous cycle. The
animals were slaughtered at a local abattoir on Days 10–
12 (the period of fully-active corpora lutea) and Days
14–16 (the luteolysis period) of the estrous cycle. Add-
itionally, the stage of the cycle was verified by utero-
ovarian morphology [33]. Immediately after the slaughter,
uteri were placed in ice-cold phosphate-buffered saline
(PBS) supplemented with 100 IU/ml penicillin (Polfa,
Poland) and 100 μg/ml streptomycin (Polfa, Poland), and
transported to the laboratory on ice within ~1 h for in
vitro tissue culture.
Preparation of endometrial and myometrial slices
Uterine horns were cut longitudinally and the endomet-
rium and the perimetrium were then separated from the
myometrium by careful scraping using scissors. The sep-
aration precision was histologically verified under a dis-
secting microscope. Tissues were cut into small pieces
and washed twice with sterile PBS. Individual endomet-
rial and myometrial slices (200–210 mg weight, 3 mm
thick) were placed separately in culture vials containing
2 ml Medium 199 supplemented with 0.1 % BSA
(Sigma), 20 μg nystatin (Sigma) and 20 μg gentamicin
(Krka, Novo Mesto, Slovenia) and then pre-incubated
under an atmosphere of 95 % O2 and 5 % CO2 at 37 °C
for 18 h. After preincubation, the culture medium was
replaced with fresh medium and the slices were incu-
bated with vehicle (control) or P4 (10−5 M; Sigma), E2
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(10−9 M; Sigma), OT (10−7 M; Sigma), AA (10−5 M;
Sigma), FSK (10 μg/mL; Sigma) and cpt-cAMP analogue
(200 μM; Sigma) for 3 or 24 h. All treatments were per-
formed in triplicate.
Total RNA isolation, cDNA synthesis and real-time
polymerase chain reaction analysis
Total RNA was extracted from the uterine explants col-
lected after in vitro culture (n = 5 cultures), using fenozol
(A&A Biotechnology, Gdansk Poland) in accordance with
the manufacturer’s instructions. RNA quality and quantity
were determined with spectrophotometry (NanoDrop ND-
1000, Thermo Scientific, Wilmington, DE, USA). Total
RNA samples were transcribed to cDNA using an En-
hanced Avian HS RT-PCR Kit (Sigma) and a mix of dNTPs
and random hexamers as primers. Real-Time PCR was per-
formed in duplicate for each sample using a 7300 Real-
Time PCR system and SYBR®Green PCR Master Mix (Life
Technologies, Grand Island, NY, USA) and specific primers
for AQP1 and AQP5 as described previously [32]. Samples
for the specificity control, non-template controls and dis-
sociation curve analysis of the amplified products were used
for each reaction. The specificity of amplifications was fur-
ther validated with electrophoresis of the PCR products in
a 2 % agarose gel and the obtained amplicons, after extrac-
tion from the gel, were then submitted to automated
sequencing using a 3730 xl DNA Analyzer (Life Technolo-
gies). The levels of gene expression were calculated with
the ΔΔ Ct method and normalized using the geometrical
means of two reference gene expressions, glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) and 18S rRNA.
SDS-PAGE and Western blot
Following isolation, the tissueswere immediately placed in
ice-cold dissection buffer (0.3M sucrose, 25mMimidazol,
1mMEDTA in ddH2O, pH7.2) containing 8.4μMleupep-
tin and 0.4mMpefabloc. As described previously [32], the
membranes were incubated overnight at 5 °C with anti-
AQPs or beta-actin antibodies, then with horseradish
peroxidase-conjugated secondary antibody (P448, diluted
1:3,000, Dako A/S, Glostrup, Denmark) in PBS-T for 1 h.
After washing with PBS-T, the antibody-antigen reaction
siteswerevisualizedwithanenhancedchemiluminescence
(ECL) system (Amersham Pharmacia Biotech, Little
Chalfont, UK) and exposed to photographic film (Hyper-
film ECL, RPN3103K, Amersham Pharmacia Biotech,
Little Chalfont, UK). The results ofWestern blotting were
quantifiedbydensitometric scanningof immunoblotswith
GelScan for Windows ver. 1.45 software (Kucharczyk,
Poland). The data was expressed as the AQP protein:
actin protein ratio in OD units. In our previous study,
we demonstrated that pre-incubation of anti-AQP1
and anti-AQP5 antibodies with the respective AQP
antigens (immunizing peptides) prevented labeling in
the porcine uterine tissues [28].
Statistical analysis
All numerical data were analyzed by one-way ANOVA
and a least significant difference (LSD) post hoc test and
were reported as the means ± S.E.M. from five independ-
ent observations. Statistical analyses were performed using
Statistica software (Stat Soft Inc., Tulsa, USA). Values for
p <0.05 were considered statistically significant.
Results
AQP1 mRNA expression in porcine endometrial and
myometrial tissues
The control abundance of AQP1 transcript from the
mid-luteal phase (Days 10–12) harvested from the endo-
metrial tissue was about 3.5-fold higher than from luteo-
lysis (Days 14–16) during 3-h incubation (p <0.05;
Fig. 1a and b). The endometrial expression of AQP1
mRNA on Days 10–12 decreased after a 3-h treatment
with P4 and OT (p <0.05), but during longer incubation
(24 h), these treatments significantly (p <0.05) increased
it (Fig. 1a). Treatments with E2 and FSK decreased (p
<0.05) AQP1 mRNA expression in the endometrium
from the mid-luteal phase, after 3- and 24-h incubations.
During luteolysis, the expression of AQP1 was strongly
elevated in response to P4, E2, OT, AA, FSK and cAMP
(p <0.05) in the endometrium after 3- and 24-h (Fig. 1b).
In the myometrium (Fig. 2a), P4 decreased (p <0.05)
AQP1 expression after 24-h incubation on Days 10–12.
Treatment of this tissue with E2 for 3-h also significantly
decreased (p <0.05) AQP1 mRNA expression, but
elevated (p <0.05) it after 24-h incubation. Incubation of
the tissue with OT elevated AQP1 mRNA expression,
but with AA and cAMP it decreased after 3-h incubation
(p <0.05). In turn, during longer incubation (24 h), FSK
elevated AQP1 gene expression (p <0.05). During luteo-
lysis, a stimulation (p <0.05) of AQP1 expression in the
myometrial tissue was observed after treatments with P4
(after 3 and 24 h), FSK and cAMP (after 3-h; p <0.05).
Incubation with E2, OT and AA did not affect the ex-
pression of AQP1 mRNA in this tissue (Fig. 2b).
AQP5 mRNA expression in porcine endometrial and
myometrial tissues
The control expression of AQP5 transcript in the
endometrial slices on Days 10–12 of the estrous cycle
was 2.5-fold and 2.0-fold higher than on Days 14–16,
after 3- and 24-h incubation, respectively (p <0.05; Fig. 3a
and b). Treatment of this tissue with E2, OT and FSK
after 3 h decreased AQP5 gene expression (p <0.05).
Treatments with P4 and OT significantly stimulated
AQP5 gene expression in this tissue following longer in-
cubation (p <0.05). In turn, treatments with E2 (3-h) and
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FSK (3- and 24-h) significantly decreased (p <0.05)
AQP5 gene expression in endometrial tissues on Days
10–12 of the estrous cycle. During luteolysis (Days 14–
16), all treatments (P4, E2, OT, AA, FSK and cAMP)
stimulated (p <0.05) the expression of AQP5 for 3 h
(Fig. 3b). The expression of AQP5 mRNA in the myome-
trium from Days 10–12 was significantly decreased after
24-h treatment with P4 (p <0.05, Fig. 4a).
Fig. 1 AQP1 mRNA and protein expression in porcine endometrial explants. The expression of AQP1 mRNA in the endometrial tissue harvested
from pigs (n = 5) on Days 10–12 (a) and 14–16 (b) of the estrous cycle after treatment with steroids (P4, E2), oxytocin (OT), arachodonic acid (AA),
forskolin (FSK) and cAMP for 3 and 24 h. The expression of the studied gene, determined by real-time PCR, is presented as means ± SEM
in relation to the expression of reference genes, GAPDH and 18 sRNA. Different letters indicate significant differences (p <0.05) between
each treatment and respective control values for 3- (a, b) or 24-h (c, d) incubations. The protein content of AQP1 was determined by
semi-quantitative Western blot analysis, in the endometrial explants harvested from pigs (n = 5) on Days 10–12 (c) and 14–16 (d) of the
cycle after treatment with the above-mentioned factors for 3 and 24 h. The data is presented as means ± SEM in relation to β-actin tissue
content. Different letters indicate significant differences (p <0.05) between each treatment and respective control values for 3- (a, b) or
24-h (c, d) incubations. Different large letters indicate significant differences (p <0.05) between the same treatments for 3- (a, b) or 24-h
(c, d) incubations for different periods (Days 10–12 and 14–16) of the estrous cycle
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The control expression of AQP5 transcript in the myo-
metrial slices during the mid-luteal phase (Days 10–12) was
significantly higher than during luteolysis (Days 14–16)
after both short (3 h) and long (24 h) incubations. On Days
10–12 of the cycle, the myometrial AQP5 expression was
reduced by E2, AA, FSK and cAMP following short incu-
bation (Fig. 4a) as well by P4, AA and cAMP during
longer incubation. In contrast, treatments with OT for
A B
C
D
Fig. 2 AQP1 mRNA and protein expression in porcine myometrial explants. The expression of AQP1 mRNA in the myometrial tissue harvested from
pigs (n = 5) on Days 10–12 (a) and 14–16 (b) of the estrous cycle after treatment with steroids (P4, E2), oxytocin (OT), arachodonic acid (AA), forskolin
(FSK) and cAMP for 3 and 24 h. The expression of the studied gene, determined by real-time PCR, is presented as means ± SEM in relation to the
expression of reference genes, GAPDH and 18 sRNA. Different letters indicate significant differences (p <0.05) between each treatment and respective
control values for 3- (a, b) or 24-h (c, d) incubations. The protein content of AQP1 was determined by semi-quantitative Western blot analysis, in the
myometrial explants harvested from pigs (n = 5) on Days 10–12 (c) and 14–16 (d) of the cycle after treatment with the abovementioned factors for 3
and 24 h. The data is presented as means ± SEM in relation to β-actin tissue content. Different letters indicate significant differences (p <0.05) between
each treatment and respective control values for 3- (a, b) or 24-h (c, d) incubations. Different large letters indicate significant differences (p <0.05)
between the same treatments for 3- (a, b) or 24-h (c, d) incubations for different periods (Days 10–12 and 14–16) of the estrous cycle
Skowronska et al. Reproductive Biology and Endocrinology  (2015) 13:131 Page 5 of 11
3 h as well as with E2, OT, FSK for 24 h stimulated
AQP5 mRNA expression during this period. During
luteolysis (Days14-16), increased AQP5 gene expression
in myometrial explants was observed in response to P4
and FSK (p <0.05, Fig. 4b) after both incubation periods.
Treatments of the myometrial slices for 3 h with E2,
OT and cAMP were significantly (p <0.05) increased,
but decreased by AA (Fig. 4b).
A B
C
D
Fig. 3 AQP5 mRNA and protein expression in porcine endometrial explants. The expression of AQP5 mRNA in the endometrial tissue harvested
from pigs (n = 5) on Days 10–12 (a) and 14–16 (b) of the estrous cycle after treatment with steroids (P4, E2), oxytocin (OT), arachodonic acid (AA),
forskolin (FSK) and cAMP for 3 and 24 h. The expression of the studied gene, determined by real-time PCR, is presented as means ± SEM in relation to the
expression of reference genes, GAPDH and 18 sRNA. Different letters indicate significant differences (p<0.05) between each treatment and respective
control values for 3- (a, b) or 24-h (c, d) incubations. The protein content of AQP5 was determined by semi-quantitative Western blot analysis, in the
endometrial explants harvested from pigs (n= 5) on Days 10–12 (c) and 14–16 (d) of the cycle after treatment with the abovementioned factors for 3 and
24 h. The data is presented as means ± SEM in relation to β-actin tissue content. Different letters indicate significant differences (p<0.05) between each
treatment and respective control values for 3- (a, b) or 24-h (c, d) incubations. Different large letters indicate significant differences (p<0.05) between the
same treatments for 3- (a, b) or 24-h (c, d) incubations for different periods (Days 10–12 and 14–16) of the estrous cycle
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Protein content of AQP1 in endometrial and myometrial
explants from Days 10–12 and 14–16 of the estrous cycle
AQP1 protein expression in the endometrium from Days
10–12 increased (p <0.05) after treatment with P4 during
3- and 24-h incubation (Fig. 1c). However, cAMP stimu-
lated (p <0.05) AQP1 expression only after longer incu-
bation (24-h). In turn, treatment with E2, OT, AA and
FSK did not influence AQP1 protein expression in the
A B
C
D
Fig. 4 AQP5 mRNA and protein expression in porcine myometrial explants. The expression of AQP5 mRNA in the myometrial tissue harvested
from pigs (n = 5) on Days 10–12 (a) and 14–16 (b) of the estrous cycle after treatment with steroids (P4, E2), oxytocin (OT), arachodonic acid (AA),
forskolin (FSK) and cAMP for 3 and 24 h. The expression of the studied gene, determined by real-time PCR, is presented as means ± SEM in relation to
the expression of reference genes, GAPDH and 18 sRNA. Different letters indicate significant differences (p <0.05) between each treatment
and respective control values for 3- (a, b) or 24-h (c, d) incubations. The protein content of AQP5 was determined by semi-quantitative
Western blot analysis, in the myometrial explants harvested from pigs (n = 5) on Days 10–12 (c) and 14–16 (d) of the cycle after treatment with the
abovementioned factors for 3 and 24 h. The data is presented as means ± SEM in relation to β-actin tissue content. Different letters indicate significant
differences (p<0.05) between each treatment and respective control values for 3- (a, b) or 24-h (c, d) incubations. Different large letters indicate significant
differences (p<0.05) between the same treatments for 3- (a, b) or 24-h (c, d) incubations for different periods (Days 10–12 and 14–16) of the estrous cycle
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endometrium during the mid-luteal phase. During luteo-
lysis (Days 14–16), AQP1 protein expression in the
endometrium significantly increased after treatment with
P4, E2, AA, FSK and cAMP during 3- and 24-h incuba-
tion (Fig. 1D; p <0.05).
AQP1 protein expression in the myometrium was signifi-
cantly up-regulated (p <0.05) by OT (after both incubation
periods) during the mid-luteal phase (Fig. 2c). E2 and FSK
elevated this AQP content (p <0.05) only after 24-h incuba-
tion. During luteolysis, AQP1 protein content significantly
increased (p <0.05) after treatment with P4, FSK and cAMP
after 3 and 24 h as well as with E2 only after longer incuba-
tion (Fig. 2d).
Comparison of the endometrial AQP1 response to ap-
plied factors between studied periods indicated that E2,
AA, FSK during 3- and 24-h treatments as well as P4
and cAMP after 3-h incubation more effectively stimu-
lated (p <0.05) this AQP expression during luteolysis
than the mid-luteal phase (Fig. 1c and d). In turn, during
the mid-luteal phase, the myometrial AQP1 expression
was more sensitive (p <0.05) to stimulatory action of OT
during both incubation periods (Fig. 2c and d).
Protein content of AQP5 in endometrial and myometrial
explants from Days 10–12 and 14–16 of the estrous cycle
The expression of AQP5 protein in endometrial explants,
representing the mid-luteal phase increased (p <0.05) after
longer treatment with P4 and, in response to AA and
cAMP, only after shorter incubation (Fig. 3c and d). During
luteolysis, the endometrial AQP5 protein content was sig-
nificantly (p <0.05) higher after treatment with P4, E2, AA,
FSK and cAMP. In addition, the endometrial AQP5 protein
expression appeared to be more sensitive to treatment with
E2, AA, FSK and cAMP (during both incubation periods)
as well as P4 (short incubation) during luteolysis than dur-
ing the mid-luteal phase.
The expression of AQP5 in myometrial explants dur-
ing the mid-luteal phase significantly increased (p <0.05)
after treatment with P4 and OT during both incubation
periods as well as in response to E2, FSK and cAMP
after longer incubation (Fig. 4c). During luteolysis, the
myometrial AQP5 protein content was elevated (p <0.05)
in the presence of P4, E2 and FSK after 3- and 24-h in-
cubations as well as OT after 3-h and cAMP after 24-h
treatments (Fig. 4d). Moreover, the responsiveness of
myometrial AQP5 to P4 (both incubation periods) and
E2, FSK (short incubation) was more pronounced (p
<0.05) on Days 14–16 than on Days 10–12 of the cycle.
Conversely, OT was more effective during the mid-luteal
phase than during luteolysis (Fig. 4c and d).
Discussion
In this study, the responses of AQP1 and AQP5 to P4, E2,
OT, AA, FSK and cAMP in the porcine endometrium and
myometrium during the mid-luteal phase and luteolysis are
delineated. The basal expression of AQP1 and AQP5
mRNA in the endometrium on Days 10–12 appeared to be
higher (approx. 5- and 2-fold, respectively) than on Days
14–16 of the estrous cycle. In the myometrium, the
AQP5 transcript was also higher on Days 10–12 ver-
sus Days 14–16 of the cycle. In turn, the responses of
AQPs mRNAs and their proteins to the examined factors
in the myometrium and endometrium were more pro-
nounced during luteolysis than the mid-luteal phase.
In previous studies performed with rodents, the expres-
sion of AQP1 and AQP5 appeared to be sensitive to estro-
gens and/or P4 regulatory action [23, 34–37]. Hildebrand
et al. [38] confirmed AQP1 expression in the human endo-
metrium during a normal cycle and found its increase after
treatment with mifepristone (an anti-progestogenic steroid).
In the present study, P4 unanimously up-regulated AQP1
and AQP5 mRNA and protein expression in the endomet-
rium during luteolysis as well as in the mid-luteal phase
during longer incubation, but the responses were differenti-
ated during shorter incubation. In the myometrium, the ex-
pression of AQPs mRNAs and proteins were up-regulated
in the presence of P4 during luteolysis. In turn, on Days
10–12 of the cycle, only the abundance of both AQPs pro-
teins increased. In our recent in vitro studies [32], per-
formed with the porcine uterine explants, consisting of
endometrium and myometrium, P4 evidently stimulated
the expression of both AQPs at the protein level, but
mostly inhibited it at the transcriptional level. The data sug-
gests that P4 is an important regulator of AQP1 and AQP5
expression in the porcine uterus, particularly in the endo-
metrium. In addition, it should be noted that under physio-
logical conditions, during the mid-luteal phase, P4 secreted
by corpus luteum (CL) is to a certain degree responsible for
modulation of the uterine expression of AQPs, while during
luteolysis, locally-produced P4 (by the endometrium and
myometrium [5, 39]) seems to be mainly engaged in this
regulation. In the present experiment, E2 did not affect
AQP1 and AQP5 gene and protein expression in the endo-
metrial slices from the mid-luteal phase. In contrast, during
luteolysis, E2 evidently exerted stimulatory effects on the
endometrial expression of both AQPs at mRNA and pro-
tein level. The treatment of myometrial tissue with E2 (for
24 h) similarly stimulated these AQPs during the mid-
luteal phase, but during luteolysis only their proteins were
up-regulated. In turn, in the experiment performed with
whole uterine tissue explants [32], E2 clearly stimulated the
expression of AQP1 and AQP5 at the protein level during
both studied periods, but its influence on the expression of
AQPsmRNA was differentiated. In literature, data concern-
ing the effect of steroid hormones on the in vitro expres-
sion of AQP1/5 in separated uterine tissues from cyclic
females is not available. Li et al. [35] observed the effect of
E2 on the expression of water channel gene (AQP-CHIP).
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It was shown that endometrial AQP2 expression correlates
with serum E2 and P4 concentrations [40] and that, in the
rat uterus, the AQP5 gene is activated by estrogens [36]
and AQP5 protein is up-regulated by P4 [37]. In turn,
AQP1 appeared to be slightly regulated by E2 in the myo-
metrium [23]. On the basis of our results, it seems that
endometrium and myometrium uterine tissues exhibit their
own profiles of AQPs expression in response to P4 and E2.
Moreover, it appears that the action of steroid hormones
within the uterus during the estrous cycle also includes
their influence on the expression of AQPs, which reacted
with quantitative and qualitative changes related to differ-
ent processes, such as increasing secretory activity and pro-
moting angiogenesis and edema [28, 41].
Previous studies have suggested that OT might be impli-
cated in the regulation of AQP expression in the uterus [32,
42]. It has been reported that OT receptors are present in
the endometrium and myometrium of cyclic gilts [43, 44].
In the present study, OT increased the expression of
AQP1/AQP5 mRNAs and proteins in the myometrial slices
during the mid-luteal phase, but only AQP5 mRNA and
protein (3 h) during luteolysis. In endometrial tissue, some
responses in the expression of AQPs transcript were noted,
without any changes at the protein level. The discrepancy
between the reaction of whole and separated uterine tissues
to treatment with OT is intriguing. It might result from the
fact that conditions in separated tissues do not entirely
reflect the situation in the whole tissue explant [32], which
encompasses the endometrial/myometrial interactions
based on paracrine effects. It is known that communication
between the epithelium, stroma and myometrium is very
complex and, among others, involves locally-produced ster-
oid hormones as well as growth factors and cytokines [39],
which may affect uterine expression of AQPs. Moreover,
studies performed with rats also indicate the involvement
of OT in the regulation of AQP5, especially during late
pregnancy [42]. Collectively, it might be stated that OT is
connected with the uterine expression of AQPs in pigs, but
full explanation of its role in this process requires further
study.
Arachidonic acid is important for biosynthesis of pros-
taglandins, which play an essential role in the regulation
of reproductive processes, including luteolysis and ma-
ternal recognition of pregnancy [45–47]. In the present
study, AA did lead to up-regulation of AQP1/AQP5
mRNAs and proteins in the endometrial slices during
luteolysis. This is in agreement with our recent studies,
which demonstrated that the expression of AQP pro-
teins is stimulated in the explants of the entire uterus
during this period [32]. The observation corresponds well
with the physiologically-increased release of PGF2alpha from
the endometrium during luteolysis to cause CL regression
[48]. In turn, the endometrial synthesis of PGs is low in the
mid-luteal phase of the cycle [48, 49]. Furthermore, we did
not observe any response of AQP1 and AQP5 proteins to
AA in the myometrium during the studied periods. Import-
antly, our current findings and recently published data [32]
suggest that PGF2alpha may affect the endometrial expres-
sion of AQPs during luteolysis. However, further studies
are required to verify this hypothesis.
Our previous studies demonstrated the expression of
AQP1 and AQP5 in the porcine uterine explants in re-
sponse to forskolin and cAMP [32]. In the present study,
the stimulatory effects of forskolin and cAMP on the ex-
pression of AQP1/AQP5 mRNAs and proteins in the
endometrium and myometrium clearly dominated during
luteolysis. In contrast, results concerning the expression
of AQPs during the mid-luteal phase of the cycle were dif-
ferentiated, e.g., in the endometrium there was no re-
sponse or inhibition at the mRNA level, but no response
or stimulation at the protein level. Other studies have con-
firmed the involvement of cAMP in the regulation of
AQP5 gene expression in murine lung epithelial cell [50]
and human WISH cell [51] lines as well as human fetal
membranes [52] and amnion epithelia [53]. Our data indi-
cate the participation of the adenylate cyclase/cAMP path-
way in the intracellular transduction of signals connected
with the regulation of AQP1 and AQP5 expression in the
porcine uterine tissues, which seems to be augmented
during luteolysis, but differentiated during the mid-luteal
phase, depending on the type of tissue and the duration of
incubation.
Conclusions
In summary, the present study conducted with separated
uterine tissues has confirmed the participation of steroid
hormones (E2 and P4), OT and AA in the regulation of
AQP1 and AQP5 expression at the levels of mRNA and
protein in the endometrium and myometrium of cyclic
gilts during the mid-luteal phase and luteolysis. The re-
sponses of both AQPs to the examined factors exhibited
fluctuations, depending on the type of tissue as well as
the stage of the estrous cycle and the incubation time.
Moreover, the study indicated the involvement of the ad-
enylate cyclase/cAMP pathway in the regulation of
AQP1 and AQP5 in the porcine endometrium and myo-
metrium. The above regulations seem to be important
for cyclic changes connected with the preparation of an
intrauterine environment for proper development of em-
bryos/fetuses and successful reproduction.
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